# FDA Inspection 1043274 - GC America, Inc. - February 26, 2018

Source: https://www.keypedia.com/records/fda_inspections/gc-america-inc/c9771d0e-4bc3-424e-94dc-ea85b8078077
Source feed: FDA_Inspections

> FDA Inspection 1043274 for GC America, Inc. on February 26, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1043274
- Company Name: GC America, Inc.
- Inspection Date: 2018-02-26
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1294094 - 2025-11-07](https://www.keypedia.com/records/fda_inspections/gc-america-inc/ea996d48-c7e6-426d-8c17-97afc73f097a)
- [FDA Inspection 1273746 - 2025-06-13](https://www.keypedia.com/records/fda_inspections/gc-america-inc/71b7030a-d5be-4994-b0ce-ffb96ab58fa1)
- [FDA Inspection 1084965 - 2019-03-28](https://www.keypedia.com/records/fda_inspections/gc-america-inc/3094dd87-4470-4d34-a188-b5aca5d013b2)
- [FDA Inspection 945475 - 2015-10-26](https://www.keypedia.com/records/fda_inspections/gc-america-inc/e0fdff5d-fb59-48e3-b07c-3a1d8d8c6615)
- [FDA Inspection 891012 - 2014-06-06](https://www.keypedia.com/records/fda_inspections/gc-america-inc/1d1f2512-2297-456e-bb30-84392d1ff96d)

Company: https://www.keypedia.com/companies/gc-america-inc/ef0ee3f7-2cac-4212-8512-b78c9d54b20d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c